A Study of Antipsychotics in Individuals at Clinical High-risk for Psychosis (the SHARP-2 Study)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The current study will improve knowledge on the effectiveness and safety of the use of antipsychotics at the prodromal phase and on factors influencing the outcome, and will eventually facilitate optimisation of individualised interventions for psychosis prevention and treatment.
Epistemonikos ID: 2987bcdd097504ebb749856cad643197929961d1
First added on: May 22, 2024